Industry Experts

Audrey Kelleman, Ph.D., has more than 20 years of experience in the CDMO industry spanning clinical development, manufacturing operations, business strategy and commercial operations across a range of modalities including peptides, small molecules, and cell and gene therapies. She is passionate about helping innovator partners get their treatments to patients and streamlining operations to deliver on commitments. Audrey earned a Ph.D. in Synthetic Organic Chemistry (with a focus on peptides) from University of California, San Diego under Professor Murray Goodman.